COVERAGE HUB
$ENTX
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
LOW
score: -0.50
SENTIMENT
BULLISH
TOTAL VIEWS
0
2-DAY GRADE TIMELINE
2026-06-15
TODAY
RECENT COVERAGE · 2 ARTICLES
Entera Bio Ltd. (ENTX) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow (NASDAQ:ENTX) 2026-06-16
ENTX presented clinical or pipeline data at the Endocrine Society's Annual Meeting (ENDO 2026), a standard industry conference for...
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
ENTX presented clinical data for EB613, a first-in-class oral parathyroid hormone analog targeting osteoporosis treatment. The company...
RELATED TICKERS